Skip to main content

Corticobasal Degeneration

Corticobasal Degeneration

Corticobasal ganglionic degeneration present with asymmetric basal ganglia (akinesia, rigidity, dystonia) and cerebral cortical (apraxia, cortical sensory loss, alien limb) manifestations. We see the alien limb with parietal lobe, medial frontal lobe, and corpus callosum pathology. Dementia is a variable but may be the presenting symptom. 

Oculomotor involvement like that in progressive supranuclear palsy may occur. But the major difference between PSP and corticobasal degeneration is that the latter is with limb coordination problems, and the former is with balance and walking problems. 

Prognosis

Survival ranges from 2.5 to 12 years, with a median of about 8 years. 

Neuropathology

Corticobasal degeneration pathology shows abundant ballooned, achromatic neurons, and focal cortical atrophy predominating in medial frontal and parietal lobes, plus degeneration of the substantia nigra. We also see astrocytic plaques in the cortex. corticobasal degeneration: neuronal tau pathology shows wispy, fine-threaded tau incus. Magnetic resonance imaging may show asymmetric atrophy in the frontal and parietal lobes contralateral to the dominantly affected limbs. 

Treatment

We have limited treatment options for corticobasal degeneration, with only a minority of patients responding to L-dopa preparations given for parkinsonism. Myoclonus may respond to benzodiazepines, particularly clonazepam. No specific treatment for dementia is available, but it may not be cholinergic, suggesting that cholinesterase inhibitors are of limited value. Depression is common in corticobasal degeneration, but few data exist on treatment response. 

Clinical Manual of Neuropsychiatry, 2017









Comments

Popular posts from this blog

ICD-11 Criteria for Single Episode Depressive Disorder (Depressive Episode) (6A70)

ICD-11 Criteria for Single Episode Depressive Disorder (Depressive Episode) (6A70) Single episode depressive disorder is characterised by the presence or history of one depressive episode when there is no history of prior depressive episodes. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a bipolar disorder. Exclusions:              Recurrent depressive disorder (6A71) Adjustment disorder (6B43) Bipolar...

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:    ...

ICD-11 Criteria for Bipolar Type-1 Disorder

ICD-11 Criteria for Bipolar Type-1 Disorder    6A60     Bipolar type I disorder is an episodic mood disorder defined by the occurrence of one or more manic or mixed episodes. A manic episode is an extreme mood state lasting at least one week unless shortened by a treatment intervention characterised by euphoria, irritability, or expansiveness, and by increased activity or a subjective experience of increased energy, accompanied by other characteristic symptoms such as rapid or pressured speech, flight of ideas, increased self-esteem or grandiosity, decreased need for sleep, distractibility, impulsive or reckless behaviour, and rapid changes among different mood states (i.e., mood lability). A mixed episode is characterised by the presence of several prominent manic and several prominent depressive symptoms consistent with those observed in manic episodes and depressive episodes, which either occur simultaneously or alternate very rapidly (from day to day or with...